Genital Herpes
📧 Sign up to get email alerts when something new happens for Genital Herpes.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2021-11-01FDA Approved: ACYCLOVIR — Supplemental Application (Amneal Pharmaceuticals LLC)
The FDA approved Amneal Pharmaceuticals LLC's supplemental application for acyclovir.
-
CLINICAL_TRIALS trial_result · 2021-09-17Clinical Trial Update: Comparative Effectiveness of Treatment Options for Genital Herpes Infection to Reduce Adverse Pregnancy Outcomes
Clinical trial assessing comparative effectiveness of treatment options for genital herpes infection to reduce adverse pregnancy outcomes; c…
-
CLINICAL_TRIALS trial_result · 2021-07-13Clinical Trial Update: Biological Efficacy Study of HerpV Vaccine With QS-21 to Treat Participants With Recurrent Genital Herpes [Phase 2]
Phase 2 trial evaluating the biological efficacy of HerpV vaccine with QS-21 for recurrent genital herpes due to HSV-2; study completed and …
-
FDA approval · 2020-12-23FDA Approved: ACYCLOVIR — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for acyclovir submitted by Teva Pharmaceuticals USA, Inc.
-
CLINICAL_TRIALS trial_result · 2020-11-24Clinical Trial Update: A Clinical Research Study For The Suppression And Treatment Of Genital Herpes Infection In HIV-Infected Persons [Phase 4]
A Phase 4 clinical trial studying suppression and treatment of genital herpes infection in HIV-infected individuals was terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA label_change · 2020-09-03FDA Approved: FAMCICLOVIR — Supplemental Application (Camber Pharmaceuticals, Inc.)
The FDA approved Camber Pharmaceuticals' supplemental application for famciclovir, updating the labeling for this generic antiviral.
-
FDA approval · 2020-07-10FDA Approved: ACYCLOVIR — Original Application (ANI Pharmaceuticals, Inc.)
FDA approved ANI Pharmaceuticals' original ANDA for generic acyclovir (acyclovir). The approval covers treatment of herpes simplex infection…
-
FDA approval · 2020-03-18FDA Approved: VALACYCLOVIR — Original Application (Westminster Pharmaceuticals, LLC)
FDA approved Westminster Pharmaceuticals' original ANDA for valacyclovir (valacyclovir hydrochloride), a generic antiviral used to treat her…
-
FDA approval · 2020-02-28FDA Approved: VALACYCLOVIR — Supplemental Application (SUN PHARMACEUTICAL INDUSTRIES, INC.)
The FDA approved a supplemental application for valacyclovir from Sun Pharmaceutical Industries, Inc., resulting in changes to the product's…
-
CLINICAL_TRIALS trial_result · 2020-02-13Clinical Trial Update: The VIBLOK SAfety and perFormancE Trial [NA]
Clinical trial update for a safety and performance study related to HSV-2 infection/genital herpes; status completed with results posted in …
-
FDA approval · 2020-01-29FDA Approved: ACYCLOVIR — Original Application (Xiromed, LLC)
FDA approved the original ANDA for acyclovir from Xiromed, LLC, providing a generic version of the antiviral for herpes simplex virus infect…
-
CLINICAL_TRIALS trial_result · 2020-01-29Clinical Trial Update: Effect of HSV-2 Suppressive Therapy on Sexual Behavior [Phase 4]
Phase 4 trial investigating the effect of HSV-2 suppressive therapy on sexual behavior in individuals with genital herpes; study terminated …
-
FDA approval · 2019-07-25FDA Approved: FAMCICLOVIR — Supplemental Application (Apotex Corp.)
FDA approved a supplemental application for famciclovir filed by Apotex Corp.
-
FDA approval · 2019-07-25FDA Approved: FAMCICLOVIR — Supplemental Application (Macleods Pharmaceuticals Limited)
The FDA approved a supplemental application for famciclovir from Macleods Pharmaceuticals Limited under an ANDA.
-
CLINICAL_TRIALS trial_result · 2019-02-27Clinical Trial Update: Safety and Efficacy Trial of DNA Vaccines to Treat Genital Herpes in Adults [Phase 1, Phase 2]
Phase 1/2 clinical trial update evaluating DNA vaccines for genital herpes caused by HSV-2; trial completed.
-
CLINICAL_TRIALS trial_result · 2019-02-19Clinical Trial Update: Maintenance Dose Study of GEN-003 in Subjects With Genital Herpes Infection [Phase 2]
Phase 2 maintenance-dose study of GEN-003 in subjects with genital herpes (HSV-2 infection) was terminated; results were posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-02-15Clinical Trial Update: A Study Comparing Daily Treatment With Valaciclovir To Placebo For Suppression Of Herpes Simplex Virus HSV-2 Genital Herpes In Newly Diagnosed Patients. VALTREX® Tablet is a Trademark of the GlaxoSmithKline Group of Companies. [Phase 4]
Phase 4 trial comparing daily valacyclovir to placebo for suppression of genital herpes (HSV-2) in newly diagnosed patients; study completed…
-
CLINICAL_TRIALS trial_result · 2018-10-12Clinical Trial Update: Herpes Simplex Virus Type 2 (HSV-2) Suppression to Prevent HIV Transmission [Phase 3]
Phase 3 clinical trial update on HSV-2 suppression to reduce HIV transmission in individuals with HIV infection and genital herpes; study co…
-
FDA approval · 2018-08-31FDA Approved: ACYCLOVIR — Original Application (Zydus Pharmaceuticals (USA) Inc.)
FDA approved the original application for acyclovir from Zydus Pharmaceuticals (USA) Inc., enabling a generic version of acyclovir.
-
CLINICAL_TRIALS trial_result · 2018-06-01Clinical Trial Update: Safety and Immunogenicity Study of Therapeutic HSV-2 Vaccine [Phase 1, Phase 2]
Completion of a Phase 1/Phase 2 safety and immunogenicity study of a therapeutic vaccine for genital herpes caused by HSV-2, conducted by Ge…
-
CLINICAL_TRIALS trial_result · 2018-03-23Clinical Trial Update: VALTREX(Valacyclovir) Once Daily for Viral Shedding In Subjects Newly Diagnosed With HSV-2 [Phase 4]
A Phase 4 trial assessed once-daily valacyclovir (Valtrex) for reducing HSV-2 viral shedding in individuals newly diagnosed with genital her…
-
CLINICAL_TRIALS trial_result · 2018-02-12Clinical Trial Update: VALTREX Once Daily For Viral Shedding In Herpes Simplex Virus 2 (HSV-2) Seropositive Subjects. VALTREX® Tablet is a Trademark of GlaxoSmithKline Group of Companies. [Phase 4]
Phase 4 trial updating viral shedding results for VALTREX (valacyclovir) in HSV-2 seropositive subjects; study completed with results posted…
-
CLINICAL_TRIALS trial_result · 2017-12-07Clinical Trial Update: A Study With ASP2151 in Subjects With Recurrent Episodes of Genital Herpes [Phase 2]
A Phase 2 study of ASP2151 in subjects with recurrent genital herpes has completed.
-
CLINICAL_TRIALS trial_result · 2017-10-16Clinical Trial Update: Dose Ranging Safety and Efficacy of Therapeutic HSV-2 Vaccine [Phase 2]
Phase 2 dose-ranging study of a therapeutic HSV-2 vaccine by Genocea Biosciences completed, reporting safety and efficacy data in genital he…
-
CLINICAL_TRIALS trial_result · 2017-10-16Clinical Trial Update: Rollover Trial for Placebo Subjects Previously Enrolled Into GEN-003-002 Study [Phase 2]
Phase 2 rollover trial update for placebo subjects previously enrolled in GEN-003-002 in genital herpes has completed.